XML 41 R20.htm IDEA: XBRL DOCUMENT v3.6.0.2
Stock Incentive Plans
12 Months Ended
Dec. 31, 2016
Stock Incentive Plans [Abstract]  
Stock Incentive Plans

14. Stock Incentive Plans

In May 2016, our shareholders approved the 2016 Long-Term Incentive Plan (“2016 Plan”), which authorizes up to 10,000,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. Awards granted after May 5, 2016 will be issued out of the 2016 Plan. The awards granted under the Amended and Restated 2005 Long-Term Incentive Plan continue to vest and options expire ten years from the date of grant. Our non-employee directors, officers and key employees are eligible to participate in the 2016 Plan. The 2016 Plan allows for the issuance of, among other things, stock options, stock appreciation rights, restricted stock, deferred stock units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three to five years. Options expire ten years from the date of grant.

Under our long-term incentive plan, certain restricted stock awards are performance based. We will grant a target number of restricted stock units, with the ultimate award determined by the total shareholder return and operating performance metrics, measured in each case over a measurement period of three years. One third of the award will vest immediately at the end of the three year performance period, one third will vest a year after the performance period, and the remaining one third will vest two years after the performance period. Compensation expense for these performance grants is measured based on the probability of achievement of certain performance goals and is recognized over both the performance period and vesting period. For the portion of the grant for which the award is determined by the operating performance metrics, the estimated compensation cost was based on the grant date closing price and management’s estimate of corporate achievement for the financial metrics. If the estimated number of performance based restricted stock to be earned changes, an adjustment will be recorded to recognize the accumulated difference between the revised and previous estimates. For the portion of the grant determined by the total shareholder return, management used a Monte Carlo model to assess the compensation cost. The expected term represents the period from the grant date to the end of the three-year performance period.

The estimated compensation cost for each performance based plan was derived using the assumptions presented in the following table:

Risk Free RatesVolatility(1)Dividend Yield
2015-2017 Program0.16% - 1.16%13.64% - 42.75%4.818%
2016-2018 Program0.40% - 1.07%15.75% - 38.61%5.039%
(1) Figures use 50% historical and 50% implied volatility.

The following table summarizes compensation expense recognized for the periods presented (in thousands):

Year Ended December 31,
201620152014
Stock options$266$698$912
Restricted stock28,60330,14631,163
$28,869$30,844$32,075

Stock Options

     We have not granted stock options since the year ended December 31, 2012 but some remain outstanding. As of December 31, 2016, there was no unrecognized compensation expense related to unvested stock options. Stock options outstanding at December 31, 2016 have an aggregate intrinsic value of $5,553,000.

Restricted Stock

The fair value of the restricted stock is equal to the market price of the Company’s common stock on the date of grant and is amortized over the vesting periods.   As of December 31, 2016, there was $32,830,000 of total unrecognized compensation expense related to unvested restricted stock that is expected to be recognized over a weighted-average period of three years. The following table summarizes information about non-vested restricted stock incentive awards as of and for the year ended December 31, 2016:

Restricted Stock
Number ofWeighted-Average
SharesGrant Date
(000's)Fair Value
Non-vested at December 31, 2015 638$62.00
Vested (396)64.36
Granted 78559.42
Terminated (40)62.64
Non-vested at December 31, 2016 987$58.98